全关节置换术后假体周围关节感染术前风险计算器的开发与评估
该回顾性研究基于2000至2014年单中心27,717例(12,086例全膝关节置换和31,167例全髋关节置换,含1,035例确诊假体周围关节感染)患者,建立并外部验证(独立机构29,252例)术前假体周围关节感染风险计算器,用于评估任何假体周围关节感染、金黄色葡萄球菌假体周围关节感染和耐药菌假体周围关节感染风险。
要点
- 最终模型纳入17个显著风险因素,包括既往开放手术、药物滥用、翻修手术和HIV/AIDS。
- 内部与外部验证的曲线下面积:任何假体周围关节感染分别为0.83和0.84,耐药菌假体周围关节感染分别为0.86和0.83,金黄色葡萄球菌假体周围关节感染分别为0.86和0.73。
- 风险评分最低十分位假体周围关节感染率为0.56%和0.61%,最高十分位为15.85%和20.63%。
核心结论
- 该大型队列研究识别并验证了预测假体周围关节感染的风险因素及其相对权重。
- 在决定是否行全关节置换术及与患者沟通时,应考虑既往手术史和高风险合并症等因素。
研究设计与样本
- 回顾性研究,纳入2000至2014年单中心27,717例患者(12,086例全膝关节置换和31,167例全髋关节置换),其中1,035例确诊假体周围关节感染。
- 评估42项风险因素,采用多变量分析并将系数缩放为整数评分。
- 使用独立机构29,252例全关节置换术患者数据进行外部验证。
主要发现
- 42项风险因素中25项对假体周围关节感染不显著。
- 剩余17项中影响最大的包括既往开放手术、药物滥用、翻修手术和HIV/AIDS。
- 内部与外部验证曲线下面积:任何假体周围关节感染分别为0.83和0.84,耐药菌假体周围关节感染分别为0.86和0.83,金黄色葡萄球菌假体周围关节感染分别为0.86和0.73。
- 风险评分最低十分位假体周围关节感染率为0.56%和0.61%,最高十分位为15.85%和20.63%。
关键数值与推荐
- 最终模型纳入17个显著风险因素。
- 内部验证曲线下面积:任何假体周围关节感染0.83,耐药菌假体周围关节感染0.86,金黄色葡萄球菌假体周围关节感染0.86。
- 外部验证曲线下面积:任何假体周围关节感染0.84,耐药菌假体周围关节感染0.83,金黄色葡萄球菌假体周围关节感染0.73。
- 最低十分位假体周围关节感染率0.56%和0.61%,最高十分位15.85%和20.63%。
临床怎么用
- 作者认为,在决定是否行全关节置换术及与患者沟通时,应考虑既往手术史和高风险合并症等因素。
局限性
- 证据等级为预后Level IV。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preoperative identification of patients at risk for periprosthetic joint infection (PJI) following total hip arthroplasty (THA) or total knee arthroplasty (TKA) is important for patient optimization and targeted prevention. The purpose of this study was to create a preoperative PJI risk calculator for assessing a patient's individual risk of developing (1) any PJI, (2) PJI caused by Staphylococcus aureus, and (3) PJI caused by antibiotic-resistant organisms. METHODS: A retrospective review was performed of 27,717 patients (12,086 TKAs and 31,167 THAs), including 1,035 with confirmed PJI, who were treated at a single institution from 2000 to 2014. A total of 42 risk factors, including patient characteristics and surgical variables, were evaluated with a multivariate analysis in which coefficients were scaled to produce integer scores. External validation was performed with use of data on 29,252 patients who had undergone total joint arthroplasty (TJA) at an independent institution. RESULTS: Of the 42 risk factors studied, 25 were found not to be significant risk factors for PJI. The most influential of the remaining 17 included a previous open surgical procedure, drug abuse, a revision procedure, and human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS). The areas under the curves were 0.83 and 0.84 for any PJI, 0.86 and 0.83 for antibiotic-resistant PJI, and 0.86 and 0.73 for S. aureus PJI in the internal and external validation models, respectively. The rates of PJI were 0.56% and 0.61% in the lowest decile of risk scores and 15.85% and 20.63% in the highest decile. CONCLUSIONS: In this large-cohort study, we were able to identify and validate risk factors and their relative weights for predicting PJI. Factors such as prior surgical procedures and high-risk comorbidities should be considered when determining whether TJA is indicated and when counseling patients. LEVEL OF EVIDENCE: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Tan TL, Maltenfort MG, Chen AF, et al. Development and Evaluation of a Preoperative Risk Calculator for Periprosthetic Joint Infection Following Total Joint Arthroplasty. J Bone Joint Surg Am. 2018. PMID: 29715226. doi:10.2106/JBJS.16.01435
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。